Circulating microRNAs in Fabry Disease
Abstract Fabry disease is an X-linked deficiency of the lysosomal hydrolase alpha-galactosidase A (alpha-Gal). This results in an accumulation of globotriaosylceramide (GL-3/Gb3) in a variety of cells with subsequent functional impairment. The continuous progress of FD often leads to decreased quali...
Main Authors: | Ke Xiao, Dongchao Lu, Jeannine Hoepfner, Laura Santer, Shashi Gupta, Angelika Pfanne, Sabrina Thum, Malte Lenders, Eva Brand, Peter Nordbeck, Thomas Thum |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2019-10-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-019-51805-6 |
Similar Items
-
MicroRNAs in Serum and Bile of Patients with Primary Sclerosing Cholangitis and/or Cholangiocarcinoma.
by: Torsten Voigtländer, et al.
Published: (2015-01-01) -
Circulating microRNAs are not eliminated by hemodialysis.
by: Filippo Martino, et al.
Published: (2012-01-01) -
MicroRNAs regulating superoxide dismutase 2 are new circulating biomarkers of heart failure
by: Emilie Dubois-Deruy, et al.
Published: (2017-11-01) -
In Vitro and In Vivo Amenability to Migalastat in Fabry Disease
by: Malte Lenders, et al.
Published: (2020-12-01) -
Neutralizing anti-drug antibodies in Fabry disease have no obvious clinical impact?
by: Malte Lenders, et al.
Published: (2018-09-01)